Skip to main content

Dynamic Assessment of Pregnancies and Infants

Help answer questions about maternal and infant health


Understanding maternal health outcomes

Critical to ensuring the well-being of both pregnant women and babies is an understanding of how various medications may affect them. Yet evidence can be difficult to find. Optum® Dynamic Assessment of Pregnancies and Infants (DAPI) links women and their infants’ health data to answer questions about maternal health.

The resulting database allows researchers to track women's exposures and the medications they took before and during pregnancy, then link those exposures to infants in utero. We examine these exposures in relation to pregnancy outcomes and infant health outcomes.

Linking women and their infant's health data



Growing depth of data

Our database includes approximately 200,000 pregnancies per calendar year.


Help patients and providers make decisions

Tap into our connected claims and medical records databases to contribute to public health knowledge.


Support regulatory agencies

Meet regulatory standards and requests for drug labeling.

Understanding the health of women and babies

DAPI has the powerful capability to link the health data of women and their infants within the Optum claims-based research database.


Pregnancy attributes

Discover data variables that may be of interest as we work together to address your study objectives.


Work with us

Collaborate with the Optum team to fill in the gaps in data on the safety of medicines when used during pregnancy.

Resource library

Fact sheet

Understanding the health of women and babies

Explore a broader view of maternal and infant health.


Optum Epidemiology overview

Learn how Optum Epidemiology informs public heath and drives clinical decisions.


Studying impacts of treatments on pregnancy

When ‘Is it safe for me?’ changes to ‘Is it safe for us?’

Additional resources

Partner with Our Epidemiology Consultants

Advance public health and safety with our trusted experts and data.

Gain Greater Insights Through Clinicogenomics

Better understand diseases and drug development opportunities.

Strengthen Your Value Story with HEOR

Tap into our expertise in health economics and outcomes research.